Joseph Burnett is CEO & President at ClearPoint Neuro, Inc. (CLPT). They have made 2 open-market trades across 1 company since 2025, most recently 2026-09-02.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLPT | 130,720 | $1.2M |
Shares reported on the most recent Form 4, priced at the 2026-09-03 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLPT | SELL · 10b5-1 | 2026-06-29 | 2026-07-01 | $19.38 | $388K | -15.4% | -20.6% | -37.6% |
| CLPT | SELL · 10b5-1 | 2026-06-17 | 2026-06-22 | $17.79 | $1.1M | +12.6% | -9.7% | -15.9% |
| CLPT | SELL · 10b5-1 | 2026-02-25 | 2026-02-26 | $15.17 | $303K | -18.6% | -37.6% | -17.2% |
| CLPT | SELL · 10b5-1 | 2026-01-26 | 2026-01-27 | $15.57 | $46K | -6.8% | -0.1% | -22.2% |
| CLPT | SELL | 2026-01-09 | 2026-01-13 | $16.12 | $322K | -1.5% | -9.6% | -30.7% |
| CLPT | SELL · 10b5-1 | 2025-10-10 | 2025-10-14 | $26.97 | $1.4M | -4.8% | -40.4% | -39.8% |
| CLPT | SELL | 2025-06-09 | 2025-06-11 | $13.29 | $565K | -7.8% | -9.6% | -13.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.